The Genetic Testing Market is being driven by Rising prevalence of genetic diseases and disorders
The Genetic Testing Market is expected to grow at a CAGR of 15.2% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 11058.8 million. The Human Genome Project's completion and the emergence of next-generation sequencing (NGS) technologies have revolutionized the genetic testing market. These advancements have granted market players access to a comprehensive database of human genomes, facilitating the exploration of genetic functionalities and structures. NGS technology has significantly advanced genetic research by enabling large-scale human genome sequencing, allowing for the detection of intermediate to large-size mutations and gene variants responsible for various diseases and disorders. Moreover, NGS has drastically reduced the cost of sequencing, genomic analysis, and database management, instigating a transformative impact on the global genetic testing industry.
Get more information on Genetic Testing Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
239 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 15.2% |
Market growth 2025-2029 |
USD 11058.8 million |
Market structure |
market_structure.ucfirst |
YoY growth 2024-2025(%) |
12.9 |
Key countries |
US, Germany, Canada, UK, France, China, Japan, Italy, India, and South Korea |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Genetic Testing Market encompasses various techniques such as Targeted Sequencing, SNP Arrays, Chromosomal Microarray Analysis, Haplotype Analysis, and others. These technologies are used in Population Genetics, Biomarker Discovery, Drug Development, Clinical Trials, Genetic Epidemiology, and Population Genomics. Genetic Diversity, Genome Editing, Gene Knockouts, and Gene Silencing are also part of this market. Applications include Synthetic Biology, Methylation Profiling, Microbiome Analysis, Mitochondrial DNA Testing, Forensic Genetics, Animal Genetics, Plant Genetics, Agricultural Biotechnology, and Genetic Improvement. Personalized Healthcare, Digital Health, Artificial Intelligence (AI), Machine Learning, Big Data, and Cloud Computing are driving the market's growth. Data Privacy Regulations, Genetic Discrimination, Ethical Guidelines, Patient Advocacy, Consumer Awareness, Genetic Counseling Services, Genetic Testing Panels, Multi-Gene Testing, Cancer Gene Panels, Cardiovascular Gene Panels, and Neurological Gene Panels are significant considerations in this field.
The global life sciences tools and services market encompasses organizations involved in the research and development (R&D) of a range of product categories, including capital equipment, instruments, accessories, and consumables. These products are utilized in the pharmaceutical and biotechnology industries, as well as in laboratory diagnosis of various diseases. The market size is determined by the combined revenue generated by manufacturers of these tools and services. Factors driving market growth include the increasing global population aging, resulting in a larger demographic requiring healthcare solutions, leading to a surge in demand for genomic testing applications such as genome sequencing, DNA testing, carrier screening, prenatal testing, newborn screening, and predictive testing.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted